South China Morning Post
Shares of Chinese digital healthcare company ClouDr Group rose for a second day after it announced that it has embedded DeepSeek's artificial intelligence (AI) technology into its platform to deliver efficiency gains in hospital and pharmacy operations. The integration of the DeepSeek R1 model into the medical AI platform ClouDr Brain would bolster the platform's data-mining capabilities to boost clients' efficiency in handling patients with chronic conditions, Kuang Ming, chairman and CEO, said